COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Sep 27, 2023

SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer

Jan 24, 2023

SaNOtize Announces Inaugural Scientific Advisory Board

Jan 17, 2023

SaNOtize Names John Sharp Chief Financial Officer

Aug 24, 2022

SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Jul 13, 2022

Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

For More Press Releases

---